| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 75 | 150 | 1,963 | 7,773 | | Cost of Revenue | (17,192) | 139 | 8,421 | 8,719 | | | Gross Profit | 3 | 11 | (6,458) | (946) | | | Operating Expenses | | Research Development | 1,653 | 1,964 | 211 | 53 | | Selling General and Administrative | 2,515 | 1,023 | 9,445 | 5,212 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 720 | 1,459 |
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,885) | (4,435) | (16,114) | (6,211) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 99 | 58 | 24 | 20 | | Earnings Before Interest And Taxes | (4,786) | (4,377) | (16,090) | (6,192) | | Interest Expense | 9 |
-
|
-
|
-
| | Income Before Tax | (4,795) | (4,377) | (16,090) | (6,192) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,541) | (4,377) | (16,090) | (6,192) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,541) | (4,377) | (16,090) | (6,192) | | Preferred Stock And Other Adjustments | (196) | 69 | 127 | (5) | | | Net Income Applicable To Common Shares | ($4,737) | ($4,308) | ($15,963) | ($6,196) |
|
0.58% Nasdaq 
Income Statement
